Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillation
- 4 December 2015
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 173 (1), 39-52
- https://doi.org/10.1111/bph.13332
Abstract
In drug research using the rat Langendorff heart preparation, it is possible to study left ventricular (LV) contractility using an intraventricular balloon (IVB), and arrhythmogenesis during coronary ligation-induced regional ischaemia. Assessing both concurrently would halve animal requirements. We aimed to test the validity of this approach. The electrocardiogram (ECG) and LV function (IVB) were recorded during regional ischaemia of different extents in a randomized and blinded study. IVB-induced proarrhythmia was anticipated, but in hearts with an ischaemic zone (IZ) made deliberately small, an inflated IVB reduced ischaemia-induced ventricular fibrillation (VF) incidence as a trend. Repeating studies in hearts with large IZs revealed the effect to be significant. There were no changes in QT interval or other variables that might explain the effect. Insertion of an IVB that was minimally inflated had no effect on any variable compared with ‘no IVB’ controls. The antiarrhythmic effect of verapamil (a positive control drug) was unaffected by IVB inflation. Removal of an inflated (but not a non-inflated) IVB caused a release of lactate commensurate with reperfusion of an endocardial/subendocardial layer of IVB-induced ischaemia. This was confirmed by intracellular 31phosphorus (31P) nuclear magnetic resonance (NMR) spectroscopy. IVB inflation does not inhibit VF suppression by a standard drug, but it has profound antiarrhythmic effects of its own, likely to be due to inflation-induced localized ischaemia. This means rhythm and contractility cannot be assessed concurrently by this approach, with implications for drug discovery and safety assessment.This publication has 57 references indexed in Scilit:
- La distensión de la región isquémica predice una mayor inducibilidad de fibrilación ventricular tras la oclusión coronaria en el modelo porcinoRevista Espanola de Cardiologia, 2013
- Distension of the Ischemic Region Predicts Increased Ventricular Fibrillation Inducibility Following Coronary Occlusion in SwineRevista Española de Cardiología (English Edition), 2013
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?British Journal of Pharmacology, 2006
- A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesisCardiovascular Research, 1992
- The fate of inorganic phosphate and pH in regional myocardial ischemia and infarction: A noninvasive31P NMR studyMagnetic Resonance in Medicine, 1987
- Chemical ablation of ventricular tachycardia in the dogAmerican Heart Journal, 1986
- An improved perfusion apparatus for small animal heartsJournal of Pharmacological Methods, 1986
- Ventricular Resection Guided by Epicardial and Endocardial Mapping for Treatment of Recurrent Ventricular TachycardiaThe New England Journal of Medicine, 1980
- Graded global ischemia and reperfusion. Cardiac function and lactate metabolism.Circulation, 1977